advertisement

GLUCOWATCH® G2™ BIOGRAPHER

57 %
43 %
advertisement
Information about GLUCOWATCH® G2™ BIOGRAPHER
Education

Published on September 25, 2007

Author: lokesht

Source: authorstream.com

advertisement

GLUCOWATCH® G2™ BIOGRAPHERH. PETER CHASE, MD:  GLUCOWATCH® G2™ BIOGRAPHER H. PETER CHASE, MD INTRODUCTION ACCURACY DATA HOME PILOT TRIAL DIRECNET STUDY GROUP SUMMARY Slide2:  GlucoWatch® G2™ Biographer Slide3:  GlucoWatch® G2™ Biographer (GW2B) Measures interstitial glucose extracted by reverse iontophoresis Requires a single calibration value following the 2-hour warm-up period Glucose readings every 10 minutes for 13 hours Values range from 40 to 400 mg/dL Slide4:  GlucoWatch G2 Biographer INTRODUCTION i) Second generation model (G2B) ii) Warm-up 2 hours  enter BG value iii) Reverse iontophoresis: AAA battery iv) Pulls interstitial fluid (including glucose) into gel discs in Auto Sensor v) Readings as often as every 10 min for up to 13 hrs (max = 76 readings; Ave = 55) INTRO: G2B:  INTRO: G2B vi) Numerous data integrity checks are performed that monitor environmental factors (temperature, sweating), sensor function, and performance. If the reading fails the data integrity checks, it is skipped because the value may be incorrect. vii) The G2 Biographer averages the reading obtained in the most recent cycle with the reading obtained in the previous 10 minute cycle. INTRO: G2B:  INTRO: G2B vii) Alarms for: • Hypo/hyper-glycemia (level set by user) • Pending low in next 10-20 minutes • Low or drop 30 minutes prior to detection of sweat viii) Up or down arrows with change of 9mg/dl INTRO: G2B: Major uses::  INTRO: G2B: Major uses: i) Nocturnal hypoglycemia ii) Postprandial hyperglycemia iii) Hypoglycemic unawareness iv) Gestational diabetes v) Type 2 diabetes vi) Other (e.g. Glycogen Storage Dis.) G2B: Positives::  G2B: Positives: Detection of lows – particularly during the night Making aware of post-prandial highs “Watchdog” effect Detecting “patterns” e-mailing data to MD or RN INTRO: G2B:Negatives::  INTRO: G2B:Negatives: Skipped readings with sweating Not always awakening for alarm Not waterproof Skin itching, blisters, (remove sensor with Unisolve®) (adults > youth) Won’t take first calibration (6%) due to sweat, rapid BG change, weak signal Other skipped readings Slide11:  Side Effects No serious skin reactions No other problems Moderate Irritation example Mild Irritation example Slide12:  GlucoWatch Function Sensor calibration 1st attempt 94% 2nd attempt 2% Failed 4% Sensor lifespan* ≥14.5 hours (Full) 81% 10.0 to 14.5 hours 3% 6.0 to 10.0 hours 6% <6.0 hours 10% Of 14,232 possible GW2B measurements 17% were skipped Excludes sensors stopped early for logistical reasons. DirecNet Data Slide13:  Analyzer Features Analyzer alert settings may differ from Biographer settings Biographer DOWN alerts Trend arrows not shown on Analyzer screen 220 mg/dL 160 mg/dL Part II: ACCURACY STUDIES IN CHILDREN:  Part II: ACCURACY STUDIES IN CHILDREN Eastman RC, Chase HP, Buckingham B, et al. Pediatric Diabetes 3:127, 2002 Clinic setting 3 First GW Biographers/subject Multiple wear sites Compared to HemoCue® meter ACCURACY STUDIES IN CHILDREN:  ACCURACY STUDIES IN CHILDREN DirecNet Study Group i) Inpatient ii) 2 – 4 G2Bs/subject iii) Upper and lower arm sites iv) Compared to hospital lab BG ACCURACY STUDIES IN CHILDREN:  ACCURACY STUDIES IN CHILDREN GWB G2B (Pediatric Diabetes) (DirecNet) Settings Clinic (14 Hr) Inpatient (26 Hr) No. Youth 66 (11.9 yrs) 89 (9.9 yrs) Sensors 198 285 Comparisons 1313 3,659 Skipped Readings: 14% 17% ACCURACY STUDIES IN CHILDREN:  ACCURACY STUDIES IN CHILDREN GWB G2B (Pediatric Diabetes) (DirecNet) Mean Difference* -17 mg/dl 2.1 mg/dl Absolute Difference** 34 mg/dl 30.8 mg/dl iii) MARD*** 21% 22% *Mean Difference = Sensor value – Lab value **Absolute Difference= Absolute value of difference **MARD = Mean Absolute Relative Difference = Sensor value – lab value x 100 lab value ACCURACY STUDIES IN CHILDREN:  ACCURACY STUDIES IN CHILDREN GWB G2B (Pediatric Diabetes) (DirecNet) iv) Correlation Coef. 0.82 0.86 v) Consensus Error 97% 97% Grid (A + B) vi) Paired Values 76% 74% within 20% ACCURACY STUDIES IN CHILDREN:HYPOGLYCEMIA:  ACCURACY STUDIES IN CHILDREN:HYPOGLYCEMIA Overnight Hypoglycemia (<70mg/dl) 18 episodes by G2B (DirecNet) 2) 10 episodes = Lab glucose matched 8 episodes = not confirmed Slide22:  0405 BG-44 0534 BG-54 13 yo on CSII Basal rates had been erased Accidentally put in rates 12 hours off True lows detected by alarm 4/7 4/8 4/9 4/10 Slide23:  BG 177 13 yo on CSII with correct/new basal rates in place HbA1c = 7.4% 4/12 4/13 Part III: HOME PILOT STUDY:  Part III: HOME PILOT STUDY Use of the GlucoWatch Biographer (GWB) in Children with Type 1 Diabetes (T1DM) Chase HP, Roberts MD, Wightman C, Klingensmith G, Garg SK, et al. Pediatrics 111:790-794,2003. Objective: To determine the usefulness of the GWB for: 1) detection of hypoglycemia 2) improving glucose control in children and adolescents with T1DM in a home environment Slide25:  40 Randomized Study Subjects Age 7-17 years; mean = 12.4 yrs Type 1 diabetes 1 yr (mean = 6.3 yrs) HbA1c >8% on 2 occasions during prior 6 months Absence of clinically significant disease or condition that would interfere with participation in the trial No history of severe hypoglycemia for 6 months preceding entry into the trial (many had prior history of severe hypoglycemia >6 months before study) Willingness to be randomly assigned to standard care or standard care with Biographer monitoring 4 times/week Slide26:  Study Plan Randomization to two treatment groups standard care in the home environment standard care in the home environment with GlucoWatch Biographer monitoring Biographer alerts set to 70 and 300 mg/dL Confirmation of alerts by conventional blood glucose monitoring Both groups: weekly review of SMBG data (±GWB data) and a phone call from HPC Slide27:  Outcome Measures HbA1c measured at baseline, and at 1 and 3 months (DCA-2000) Hypoglycemia events determined - Biographer alert = 70 mg/dl - Hypoglycemic event = SMBG <70 mg/dl Surveys Fear of Hypoglycemia Quality of Life (DCCT) Slide28:  GWB: HOME USE Week 1-4 5-8 9-13 #Uses/wk 4.1 3.7 3.0 %Hi BG* 4.7 2.5 3.1 %Lo BG* 14.2 16.6 16.5 *GWB readings Slide29:  Frequency of Hypoglycemia Home Meter Blood Glucose < 70 mg/dL * * * p<0.05 versus control * * * * Slide30:  Median HbA1c by Group vs. Time * p<0.05 versus control group * Slide31:  Summary and Conclusions Biographer use was well tolerated in the home environment HbA1c was significantly lower (p<0.05) in the Biographer treatment group compared to the control group after 3 months of treatment Biographer users detected significantly more hypoglycemia during the day and night than non-users The Biographer is useful for improving glucose control and detecting hypoglycemia in children and adolescents with type 1 diabetes Slide32:  Using DCCT data, a decline in HbA1c from 9.0 to 8.4 for 100 subjects for a lifetime would: Prevent severe eye disease in 20 people Prevent blindness in 6 people Prevent gross kidney damage in 20 people (8 needing transplants) Prevent 6 cases of neuropathy Reduction in Complications: Eastman RC, Chase HP and Leptien AD Pediatric Diabetes 4:82-86, 2003 Slide33:  Picked up low at calibration 0733 BG 138 2 GWB tracings Pre-teen girl IDDM x 5yrs Patient at slumber party 2008 BG 56 4/18 4/19 4/15 0805 BG 305 1059 BG 259 Slide34:  4/25 5/2 1736 bg350 1511 Piano teacher gave candy but did not test 1357 bg175 Pre-teen girl IDDM x 5yrs 0908 bg245 1009 bg45 Went to office No snack given Low alarm at same time as last week (1530) No bg test 1759 bg215 1151 bg80 Part IV: DIRECNET STUDY GROUP:  Part IV: DIRECNET STUDY GROUP DIabetes REsearch in Children NETwork NIH funded collaborative study group (NICHD and NIDDK) 5 Centers: Denver, Iowa, Nemours (FL), Stanford and Yale. + Coordinating Center: = Jaeb Center for Health Research, Tampa, FL DIRECNET STUDY GROUP:  DIRECNET STUDY GROUP Objective = to critically evaluate the clinical usefulness of current and future glucose sensors in youth with T1DM. Initial inpatient study= accuracy of G2B and of CGMS. Abstracts #156 OR, #432-P and #387-P . v) Next study: Similar to the GWB Pilot Trial done in Denver, but with 200 children x 6 months. Part V: SUMMARY:  Part V: SUMMARY Purpose of the GlucoWatch Biographer: To detect trends and to track patterns in glucose levels as a supplement to SMBG (not to replace SMBG). Conclusion: The level of accuracy is sufficient for detecting trends. Pilot data shows the GWB is useful for improving glycemic control and detecting hypoglycemia in children and adolescents with T1DM.

Add a comment

Related presentations

Related pages

GlucoWatch G2 Biographer - Mendosa

You can wear the GlucoWatch like a wristwatch. It uses a low electric current to pull glucose through the skin, so it is minimally invasive. You will be ...
Read more

GlucoWatch G2 Biographer - P990026/S0008

Product Name: GlucoWatch G2 Biographer Manufacturer: Cygnus, Inc. Address: 400 Penobscot Drive, Redwood City, CA 94063 Approval Date: August 26 ...
Read more

Animas Glucowatch | Diabetesnet.com

*UPDATE* - Animas has decided that they will no longer be selling the GlucoWatch G2 Biographer system, as of July 31, 2007. They will continue to sell ...
Read more

GlucoWatch G2 Biographer | Medgadget

In a must see article at IVD Technology, we see a mention of the GlucoWatch G2 Biographer by California-based Cygnus Inc. The company describes its reverse
Read more

GlucoWatch Horizon Scanning Report

National Horizon Scanning Unit Horizon scanning report GlucoWatch® G2 Biographer for the non-invasive monitoring of glucose levels May 2004
Read more

GlucoWatch® Automatic Glucose Biographer - P990026

GlucoWatch® Automatic Glucose Biographer - P990026. ... The GlucoWatch® Biographer is used with fingerstick measurements to provide additional ...
Read more

GlucoWatch Glucose Alarm Watch - Medical Alert Watches

e-pill is currently not selling the GlucoWatch® BioGrapher by Cygnus®. To learn more about e-pill Medical Watches including MeDose, CADEX, WatchMinder ...
Read more

SUMMARY OF SAFETY AND EFFECTIVENESS DATA

SUMMARY OF SAFETY AND EFFECTIVENESS DATA . I. GENERAL INFORMATION . Device generic name: Automatic Glucose Biographer . Device trade name: GlucoWatch® G2 ...
Read more

GlucoWatch G2 Biographer - Food and Drug Administration

Title: GlucoWatch G2 Biographer Author: Author: ODE Subject: Issued: 09-26-2002 Keywords: Posted: 09-16-2002 Created Date: 9/16/2002 12:27:20 PM
Read more